logo
Should You Invest $1,000 in Quantum Computing Competitor Rigetti Computing?

Should You Invest $1,000 in Quantum Computing Competitor Rigetti Computing?

Globe and Mail2 days ago
Key Points
Rigetti Computing is a pure-play quantum computing investment.
Investors must understand the risks associated with investing in Rigetti.
A massive quantum computing market is expected to emerge by 2030.
10 stocks we like better than Rigetti Computing ›
Quantum computing is an intriguing investment field. Right now, there's a ton of money pouring into the technology, but it really isn't adding any value back into the economy. That's because it's still a fledgling technology that's working its way toward commercial viability. However, once it reaches that point, the companies involved in this space could see their stocks skyrocket alongside demand.
Rigetti Computing (NASDAQ: RGTI) is a company in the quantum computing race, and it's a popular pick among investors. However, is now the right time to invest $1,000 into the stock?
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
Image source: Getty Images.
Rigetti Computing is a high-risk, high-reward investment
Rigetti Computing is a pure play within the quantum computing investment realm, which means it's quantum computing relevancy or bust. This has several benefits and drawbacks.
On the positive side, the company is laser-focused on quantum computing and is devoting every bit of its resources to investing in the technology and bringing it to market. Additionally, if Rigetti Computing succeeds in its goal to achieve quantum computing relevancy, its stock is primed to soar because it has no revenue to speak of right now (besides some that it gets from research contracts). Rigetti Computing is only a $4 billion business, so it has immense upside if it can achieve significant growth.
The downside of investing in quantum computing pure plays is that there is no backup plan. If another competitor and its technology surpass Rigetti's, the stock becomes obsolete, and every share is worthless, ultimately sending the stock to $0. That's a grim outlook, but it's entirely within the realm of possibility.
Furthermore, because its only cash sources are various contracts, issuing new shares, or taking on debt, it doesn't have the financial backing that some of the large tech companies competing in quantum computing have. For example, one large competitor in this space is Alphabet, the parent company of Google. Over the past 12 months, Alphabet produced a jaw-dropping $75 billion in free cash flow. It means nothing for Alphabet to sink $1 billion into the quantum computing race -- a sum of money that Rigetti can only dream of.
Investing in Rigetti Computing is a high-risk endeavor, but if it pays off, shareholders could reap substantial rewards.
2030 is a key milestone in quantum computing
To invest in a stock as risky as Rigetti Computing, investors need to be assured that there's an adequate payoff should it win the quantum computing race. Quantum computing has applications in many fields, such as weather forecasting, logistics networks, and artificial intelligence (AI). Numerous other problems can likely be solved by quantum computing which haven't been explored yet.
However, it will be a few years before quantum computing becomes widespread.
Rigetti Computing estimates that before 2030, the annual value for quantum computing providers will be around $1 billion to $2 billion. However, it expects that opportunity to expand to $15 billion to $30 billion per year between 2030 and 2040. Should Rigetti capture 20% of that market, that's $3 billion in annual revenue. Since the stock is valued at around $4 billion, there's certainly plenty of room for upside.
So, should you invest $1,000 in Rigetti Computing? I'd say it depends on your portfolio size. If you have $2,000 to invest, then investing $1,000 into Rigetti Computing is a bad idea. If your portfolio is $100,000 or greater, then this may not be a bad idea if you're a firm believer that Rigetti Computing will win the quantum computing race. There's a ton of risk here, so it may be wiser to spread bets out among multiple quantum computing companies.
By keeping your position sizing small, you limit the effect if the stock price reaches zero. But if a 1% position increases 10-fold in value, your portfolio reaps the reward of an incredible investment.
Rigetti Computing is a high-risk, high-reward investment, and people need to understand this before investing any money in the stock.
Should you invest $1,000 in Rigetti Computing right now?
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 15, 2025
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

VSTS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Vestis Corporation - August 8, 2025 Deadline
VSTS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Vestis Corporation - August 8, 2025 Deadline

Globe and Mail

time13 minutes ago

  • Globe and Mail

VSTS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Vestis Corporation - August 8, 2025 Deadline

New York, New York--(Newsfile Corp. - July 22, 2025) - If you suffered a loss on your Vestis Corporation (NYSE: VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Vestis Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 2, 2024 and May 6, 2025. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis' ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to "lost business in excess of new business," but primarily on "lower adds over stops, which is how we describe volume changes with our existing customers." The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the "increasingly uncertain macro environment." Following this news, the price of Vestis' common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis' stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day. WHAT'S NEXT? If you suffered a loss in Vestis stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit

ADM to Release Second Quarter Financial Results on Aug. 5, 2025
ADM to Release Second Quarter Financial Results on Aug. 5, 2025

Globe and Mail

time13 minutes ago

  • Globe and Mail

ADM to Release Second Quarter Financial Results on Aug. 5, 2025

ADM (NYSE: ADM) will release financial results for the second quarter of 2025 before the market opens on Tuesday, Aug 5. A slide presentation will also be available for download. The company will host a webcast at 9 a.m. Central Time to discuss the results and provide a company update. To listen to the webcast or to download the slide presentation, go to A replay of the webcast will also be available for an extended period of time at About ADM ADM unlocks the power of nature to enrich the quality of life. We're an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We're a premier human and animal nutrition provider, offering one of the industry's broadest portfolios of ingredients and solutions from nature. We're a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We're a cutting-edge innovator, guiding the way to a future of new bio-based consumer and industrial solutions. And we're leading in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, our expertise and innovation are meeting critical needs from harvest to home. Learn more at

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline

Globe and Mail

time13 minutes ago

  • Globe and Mail

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline

New York, New York--(Newsfile Corp. - July 22, 2025) - If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Rocket Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket's securities at artificially inflated prices. On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made "several months" earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred. Following this news, the price of Rocket's common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket's stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day. WHAT'S NEXT? If you suffered a loss in Rocket stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store